Liu J, Shu W, Fagan M B, Nunberg J H, Lu M
Department of Biochemistry, Weill Medical College of Cornell University, New York, New York 10021, USA.
Biochemistry. 2001 Mar 6;40(9):2797-807. doi: 10.1021/bi0024759.
The envelope glycoprotein of HIV-1 consists of the surface subunit gp120 and the transmembrane subunit gp41. Binding of gp120 to target cell receptors induces a conformational change in gp41, which then mediates the fusion of viral and cellular membranes. A buried isoleucine (Ile573) in a central trimeric coiled coil within the fusion-active gp41 ectodomain core is thought to favor this conformational activation. The role of Ile573 in determining the structure and function of the gp120-gp41 complex was investigated by mutating this residue to threonine, a nonconservative substitution in HIV-1 that occurs naturally in SIV. While the introduction of Thr573 markedly destabilized the gp41 core, the three-dimensional structure of the mutant trimer of hairpins was very similar to that of the wild-type molecule. A new hydrogen-bonding interaction between the buried Thr573 and Thr569 residues appears to allow formation of the trimer-of-hairpins structure at physiological temperature. The mutant envelope glycoprotein expressed in 293T cells and incorporated within pseudotyped virions displayed only a moderate reduction in syncytium-inducing capacity and virus infectivity, respectively. Our results demonstrate that the proper folding of the gp41 core underlies the membrane fusion properties of the gp120-gp41 complex. An understanding of the gp41 activation process may suggest novel strategies for vaccine and antiviral drug development.
HIV-1的包膜糖蛋白由表面亚基gp120和跨膜亚基gp41组成。gp120与靶细胞受体的结合会诱导gp41发生构象变化,进而介导病毒膜与细胞膜的融合。融合活性gp41胞外域核心内三聚体卷曲螺旋中央的一个埋藏异亮氨酸(Ile573)被认为有利于这种构象激活。通过将该残基突变为苏氨酸来研究Ile573在确定gp120-gp41复合物结构和功能中的作用,苏氨酸在HIV-1中是一种非保守取代,在SIV中天然存在。虽然引入Thr573显著破坏了gp41核心的稳定性,但突变发夹三聚体的三维结构与野生型分子非常相似。埋藏的Thr573和Thr569残基之间新的氢键相互作用似乎允许在生理温度下形成发夹三聚体结构。在293T细胞中表达并整合到假型病毒颗粒中的突变包膜糖蛋白在诱导合胞体能力和病毒感染性方面分别仅表现出适度降低。我们的结果表明,gp41核心的正确折叠是gp120-gp41复合物膜融合特性的基础。对gp41激活过程的理解可能为疫苗和抗病毒药物开发提供新策略。